MORGAN STANLEY - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 162 filers reported holding FIBROGEN INC in Q1 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$1,207,197
-30.9%
1,399,000
+116.1%
0.00%
Q2 2023$1,747,990
-89.1%
647,403
-24.6%
0.00%
-100.0%
Q1 2023$16,014,870
+113.6%
858,246
+83.4%
0.00%
+100.0%
Q4 2022$7,497,312
+69.3%
467,997
+37.5%
0.00%0.0%
Q3 2022$4,428,000
-35.6%
340,334
-47.7%
0.00%0.0%
Q2 2022$6,871,000
+6.3%
650,766
+21.0%
0.00%0.0%
Q1 2022$6,465,000
+64.0%
537,931
+92.5%
0.00%
Q4 2021$3,941,000
+12.0%
279,458
-18.9%
0.00%
Q3 2021$3,520,000
-71.2%
344,392
-24.9%
0.00%
-100.0%
Q2 2021$12,209,000
-36.5%
458,494
-17.2%
0.00%
-33.3%
Q1 2021$19,231,000
+33.2%
554,045
+42.3%
0.00%
+50.0%
Q4 2020$14,441,000
+188.1%
389,353
+219.4%
0.00%
+100.0%
Q3 2020$5,012,000
-22.8%
121,883
-23.9%
0.00%0.0%
Q2 2020$6,495,000
+12.4%
160,222
-3.7%
0.00%
-50.0%
Q1 2020$5,778,000
-44.4%
166,300
-31.4%
0.00%0.0%
Q4 2019$10,390,000
+65.4%
242,249
+42.6%
0.00%0.0%
Q3 2019$6,281,000
-10.4%
169,851
+9.5%
0.00%0.0%
Q2 2019$7,010,000
-66.6%
155,170
-59.8%
0.00%
-66.7%
Q1 2019$20,973,000
+73.9%
385,887
+48.1%
0.01%
+50.0%
Q4 2018$12,058,000
-33.1%
260,530
-12.1%
0.00%
-20.0%
Q3 2018$18,014,000
-16.0%
296,520
-13.5%
0.01%
-16.7%
Q2 2018$21,454,000
+17.2%
342,710
-13.5%
0.01%
+20.0%
Q1 2018$18,309,000
+38.2%
396,285
+41.8%
0.01%
+25.0%
Q4 2017$13,249,000
+9.0%
279,502
+23.7%
0.00%0.0%
Q3 2017$12,159,000
+102.4%
226,014
+21.5%
0.00%
+100.0%
Q2 2017$6,007,000
-25.9%
185,993
-43.5%
0.00%
+100.0%
Q1 2017$8,108,000
-36.3%
328,966
-44.7%
0.00%
-50.0%
Q4 2016$12,738,000
+494.1%
595,322
+475.0%
0.00%
+100.0%
Q3 2016$2,144,000
+40.5%
103,533
+11.3%
0.00%0.0%
Q2 2016$1,526,000
-19.4%
92,983
+4.6%
0.00%0.0%
Q1 2016$1,893,000
-42.8%
88,883
-18.2%
0.00%0.0%
Q4 2015$3,311,000
+54.0%
108,653
+10.8%
0.00%0.0%
Q3 2015$2,150,000
-5.7%
98,073
+1.1%
0.00%0.0%
Q2 2015$2,279,000
-45.5%
96,979
-27.2%
0.00%
-50.0%
Q1 2015$4,182,000
-10.6%
133,304
-22.1%
0.00%0.0%
Q4 2014$4,680,000171,1770.00%
Other shareholders
FIBROGEN INC shareholders Q1 2022
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 305,784$8,143,0008.63%
Vantage Consulting Group Inc 605,713$16,130,0002.81%
GREAT POINT PARTNERS LLC 500,000$13,315,0002.79%
HHLR ADVISORS, LTD. 3,955,787$105,343,0001.08%
Intercontinental Wealth Advisors, LLC 191,300$5,094,0001.01%
Ikarian Capital, LLC 250,000$6,657,0000.54%
BHK Investment Advisors, LLC 45,100$1,201,0000.49%
Ikarian Capital, LLC 193,800$5,161,0000.42%
Omega Fund Management, LLC 130,646$3,479,0000.39%
Rhenman & Partners Asset Management AB 200,000$5,326,0000.36%
View complete list of FIBROGEN INC shareholders